diabetes. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: type II diabetic patient with a fasting blood sugar less than 200 milligrams per deciliter; free of a history or presence of malignancy; acute and emergency states; a history of major operations; a drug history of Immunomodulators, cytotoxic or immunosuppressive agents; no pregnancy or lactation if female; and not using insulin for diabetes control. Exclusion criteria: Participants will exclude in the case of any kind of acute diseases; hospitalization or meet the criteria mentioned in Inclusion criteria.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adiponectin. Timepoint: Baseline, 8 weeks after baseline, the end of the washout period, 8 weeks after the start of the second period. Method of measurement: ELISA.;C-reactive protein. Timepoint: Baseline, 8 weeks after baseline, the end of the washout period, 8 weeks after the start of the second period. Method of measurement: ELISA. | — |
Secondary
| Measure | Time frame |
|---|---|
| Total cholestrol. Timepoint: Baseline, 8 weeks after baseline, the end of the washout period , 8 weeks after the start of the second period of study. Method of measurement: Pars Azmun Kit.;Triglyceride. Timepoint: Baseline, 8 weeks after baseline, the end of the washout period , 8 weeks after the start of the second period of study. Method of measurement: Pars Azmun Kit.;LDL cholestrol. Timepoint: Baseline, 8 weeks after baseline, the end of the washout period , 8 weeks after the start of the second period of study. Method of measurement: Pars Azmun Kit.;HDL cholestrol. Timepoint: Baseline, 8 weeks after baseline, the end of the washout period , 8 weeks after the start of the second period of study. Method of measurement: Pars Azmun Kit.;Blood pressure. Timepoint: Baseline, 4 weeks after baseline, 8 weeks after baseline, the end of the washout period, 4 weeks after the start of the second period of study , 8 weeks after the start of the second period of study. Method of measurement: mercury manometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz University of Medical Science